speb/financial-data huggingface dataset:
Financial ratios for AVT — annual report dated 2025-06-30
Total revenue: 22200754000
Gross profit: 2384956000
Operating income: 622570000
Net income: 240217000
Capital expenditures: 147474000
Operating cash flow: 724504000
Depreciation & amortization: 125195000
Net tangible assets: 4174464000
Owner earnings: 217938000
Return on net tangible assets (%): 5.2207421120412105
Capex to operating income (%): 23.687938705687714
Buffett classification: The Great
Stock price: 52.06
P/E ratio: 17.77631748319228
Shares outstanding: 82024081
Book value: 5011495000
P/B ratio: 0.8520758090869093
Market cap (USD): 4270173656.86
Debt to equity: 0.5742216643935593
Current ratio: 2.426958477790288
Quick ratio: 1.158704334968305
Effective tax rate (%): 4.1313969405632776
Interest coverage ratio: 2.5266434525693784
COGS to revenue (%): 89.2573198189575
SG&A to revenue (%): 7.93840605593846
Free cash flow (dilution-adjusted): 540631000
Buyback yield (%): 7.10720510189195
Retained earnings: 3430193000
Inventory turnover: 3.7849020673347358
Receivables turnover: 5.130216178118753
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.791426989897563
FCF margin (%): 2.4351920659991997
Revenue growth (%): -6.5511914339481
Rule of 40 score: -4.1159993679489
Financial ratios for AVT — quarterly report dated 2025-06-30
Total revenue: 5617795000
Gross profit: 593685000
Operating income: 142513000
Net income: 6089000
Capital expenditures: 59600000
Operating cash flow: 139476000
Depreciation & amortization: 31925000
Net tangible assets: 4174464000
Owner earnings: -21586000
Return on net tangible assets (%): -0.5170963266182198
Capex to operating income (%): 41.82074617754169
Buffett classification: The Good
Stock price: 52.06
P/E ratio: 45.42351349736193
Shares outstanding: 82024081
Book value: 5011495000
P/B ratio: 0.8520758090869093
Market cap (USD): 4270173656.86
Debt to equity: 0.5742216643935593
Current ratio: 2.426958477790288
Quick ratio: 1.158704334968305
Effective tax rate (%): 17.76066990815775
Interest coverage ratio: 2.4384121823937033
COGS to revenue (%): 89.43206364774792
SG&A to revenue (%): 8.031122531171038
Free cash flow (dilution-adjusted): 73926000
Buyback yield (%): 1.1709125674473542
Retained earnings: 3430193000
Inventory turnover: 0.9596264720460473
Receivables turnover: 1.2981767553640136
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.7835418259975127
FCF margin (%): 1.3159255544212631
Revenue growth (%): 5.688578312582084
Rule of 40 score: 7.004503867003347
Financial ratios for AVT — quarterly report dated 2025-09-30
Total revenue: 5898572000
Gross profit: 614765000
Operating income: 150323000
Net income: 51745000
Capital expenditures: 24589000
Operating cash flow: -144584000
Depreciation & amortization: 30773000
Net tangible assets: 4029992000
Owner earnings: 57929000
Return on net tangible assets (%): 1.4374470222273394
Capex to operating income (%): 16.35744363803277
Buffett classification: The Great
Stock price: 51.62
P/E ratio: 29.04971466261415
Shares outstanding: 82024081
Book value: 4848101000
P/B ratio: 0.8733487733073216
Market cap (USD): 4234083061.22
Debt to equity: 0.6598624904885438
Current ratio: 2.3610363243955077
Quick ratio: 1.1216736931631122
Effective tax rate (%): 32.62720691630644
Interest coverage ratio: 2.515360931695726
COGS to revenue (%): 89.57773169506112
SG&A to revenue (%): 7.873804032569239
Free cash flow (dilution-adjusted): -178897000
Buyback yield (%): 3.2665396025591478
Retained earnings: 3316430000
Inventory turnover: 0.9747151427454581
Receivables turnover: 1.309781462238741
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.869587436603259
FCF margin (%): -3.0328866037407023
Revenue growth (%): 4.997992984792076
Rule of 40 score: 1.965106381051374
Financial ratios for AVT — quarterly report dated 2025-12-31
Total revenue: 6318955000
Gross profit: 663038000
Operating income: 171367000
Net income: 61733000
Capital expenditures: 15352000
Operating cash flow: 208242000
Depreciation & amortization: 33393000
Net tangible assets: 4111452000
Owner earnings: 79774000
Return on net tangible assets (%): 1.940287762085025
Capex to operating income (%): 8.95855094621485
Buffett classification: The Great
Stock price: 47.82
P/E ratio: 18.90436729909488
Shares outstanding: 82024081
Book value: 4937934000
P/B ratio: 0.7943385945255648
Market cap (USD): 3922391553.42
Debt to equity: 0.6414378969018217
Current ratio: 2.0668032756151153
Quick ratio: 1.0742002189742705
Effective tax rate (%): 31.335298370502194
Interest coverage ratio: 2.792903940806415
COGS to revenue (%): 89.50715743346804
SG&A to revenue (%): 7.7808909859304265
Free cash flow (dilution-adjusted): 176828000
Buyback yield (%): 0
Retained earnings: 3349695000
Inventory turnover: 1.0682617166288444
Receivables turnover: 1.2052631789762762
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.1916138640515705
FCF margin (%): 2.79837409824884
Revenue growth (%): 7.126860535058316
Rule of 40 score: 9.925234633307156
Financial ratios for BGX — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 9.91
Shares outstanding: 12708275
Market cap (USD): 125939005.25
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BGX — annual report dated 2022-12-31
Total revenue: -20767358
Net income: -22603250
Capital expenditures: 0
Operating cash flow: 43661431
Net tangible assets: 159530752
Owner earnings: -22603250
Return on net tangible assets (%): -14.168584875723521
Buffett classification: The Gruesome
Stock price: 7.87
Shares outstanding: 12708275
Book value: 159530752
P/B ratio: 0.6269269278565176
Market cap (USD): 100014124.25
Debt to equity: 0.5191457882678319
Free cash flow (dilution-adjusted): 43661431
Buyback yield (%): 0
Retained earnings: -77325474
Receivables turnover: -0.9358591737155321
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BGX — annual report dated 2023-12-31
Total revenue: 26118544
Net income: 24431546
Capital expenditures: 0
Operating cash flow: 25606881
Net tangible assets: 166920502
Owner earnings: 24431546
Return on net tangible assets (%): 14.636635827994334
Buffett classification: The Gruesome
Stock price: 9.27
P/E ratio: 4.821868794140166
Shares outstanding: 12708275
Book value: 166920502
P/B ratio: 0.7057593755019979
Market cap (USD): 117805709.25
Debt to equity: 0.4624956136304934
COGS to revenue (%): 0
SG&A to revenue (%): 4.688848658638858
Free cash flow (dilution-adjusted): 25606881
Buyback yield (%): 16.977105886742073
Retained earnings: -69908344
Receivables turnover: 7.888172578193
Capitalized R&D asset: 0
FCF margin (%): 98.04099723169868
Rule of 40 score: 98.04099723169868
Financial ratios for BGX — annual report dated 2024-12-31
Total revenue: 17635284
Net income: 16309272
Capital expenditures: 0
Operating cash flow: 12773702
Net tangible assets: 167598596
Owner earnings: 16309272
Return on net tangible assets (%): 9.73115073111949
Buffett classification: The Gruesome
Stock price: 11.11
P/E ratio: 8.656973484162874
Shares outstanding: 12708275
Book value: 167598596
P/B ratio: 0.8424231384969357
Market cap (USD): 141188935.25
Debt to equity: 0.48031428616502253
COGS to revenue (%): 0
SG&A to revenue (%): 4.936864073184191
Free cash flow (dilution-adjusted): 12773702
Buyback yield (%): 0
Retained earnings: -69230250
Receivables turnover: 1.7947056679220075
Capitalized R&D asset: 0
FCF margin (%): 72.43264128890694
Revenue growth (%): -32.47983501683708
Rule of 40 score: 39.95280627206986
Financial ratios for BGX — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 167598596
Buffett classification: The Gruesome
Stock price: 11.11
Shares outstanding: 12708275
Book value: 167598596
P/B ratio: 0.8424231384969357
Market cap (USD): 141188935.25
Debt to equity: 0.48031428616502253
Buyback yield (%): 0
Retained earnings: -69230250
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BGX — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 165948496
Buffett classification: The Gruesome
Stock price: 11.49
Shares outstanding: 12708275
Book value: 165948496
P/B ratio: 0.8798999886687735
Market cap (USD): 146018079.75
Debt to equity: 0.45797341845146944
Buyback yield (%): 0
Retained earnings: -70880350
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BLZE — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 16.89
Shares outstanding: 60014731
Market cap (USD): 1013648806.59
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BLZE — annual report dated 2022-12-31
Total revenue: 85155000
Gross profit: 43863000
Operating income: -48113000
Net income: -51398000
Capital expenditures: 7349000
Operating cash flow: -13781000
Depreciation & amortization: 20151000
Net tangible assets: 52044000
Owner earnings: -38596000
Return on net tangible assets (%): -74.16032587810314
Buffett classification: The Gruesome
Stock price: 6.15
Shares outstanding: 60014731
Book value: 68748000
P/B ratio: 5.36874666390295
Market cap (USD): 369090595.65000004
Debt to equity: 0.6616337929830686
Current ratio: 1.322084799374489
Quick ratio: 1.322084799374489
Interest coverage ratio: -11.21776637910935
COGS to revenue (%): 48.490399859080505
R&D to revenue (%): 38.87851564793612
SG&A to revenue (%): 69.13158358287828
Free cash flow (dilution-adjusted): -46813000
Buyback yield (%): 0
Retained earnings: -87741000
Receivables turnover: 27.145361810647117
Capitalized R&D asset: 33107000
ROCI (R&D-adjusted, %): -20.141902117445657
FCF margin (%): -54.97387117609066
Rule of 40 score: -54.97387117609066
Financial ratios for BLZE — annual report dated 2023-12-31
Total revenue: 102019000
Gross profit: 49857000
Operating income: -57905000
Net income: -59713000
Capital expenditures: 5143000
Operating cash flow: -7350000
Depreciation & amortization: 24912000
Net tangible assets: 12417000
Owner earnings: -39944000
Return on net tangible assets (%): -321.68800837561406
Buffett classification: The Gruesome
Stock price: 7.59
Shares outstanding: 60014731
Book value: 44938000
P/B ratio: 10.136450404779918
Market cap (USD): 455511808.28999996
Debt to equity: 1.0227201922648983
Current ratio: 0.6746544747490673
Quick ratio: 0.6746544747490673
Interest coverage ratio: -15.270305907172995
COGS to revenue (%): 51.129691528048696
R&D to revenue (%): 38.74474362618728
SG&A to revenue (%): 66.88459992746449
Free cash flow (dilution-adjusted): -52755000
Buyback yield (%): 0
Retained earnings: -147454000
Receivables turnover: 22.920467310716692
Capitalized R&D asset: 61708690
ROCI (R&D-adjusted, %): -31.24476754441212
Rosenberg metric: 0.18104932491618086
FCF margin (%): -51.71095580235055
Revenue growth (%): 19.80388702953438
Rule of 40 score: -31.907068772816167
Financial ratios for BLZE — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 6.39
Shares outstanding: 60014731
Market cap (USD): 383494131.09
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BLZE — annual report dated 2024-12-31
Total revenue: 127628000
Gross profit: 69343000
Operating income: -46289000
Net income: -48531000
Capital expenditures: 1256000
Operating cash flow: 12505000
Depreciation & amortization: 28328000
Net tangible assets: 35821000
Owner earnings: -21459000
Return on net tangible assets (%): -59.906200273582535
Buffett classification: The Gruesome
Stock price: 6.02
Shares outstanding: 60014731
Book value: 77622000
P/B ratio: 4.6544624026693455
Market cap (USD): 361288680.61999995
Debt to equity: 0.5969828141506274
Current ratio: 1.0994097286089326
Quick ratio: 1.0994097286089326
Interest coverage ratio: -12.654182613449972
COGS to revenue (%): 45.66787852195443
R&D to revenue (%): 32.98492493810136
SG&A to revenue (%): 57.615883661892376
Free cash flow (dilution-adjusted): -30305000
Buyback yield (%): 0
Retained earnings: -195985000
Receivables turnover: 21.12346904998345
Capitalized R&D asset: 79506400
ROCI (R&D-adjusted, %): -22.54046766889017
Rosenberg metric: 0.49297948237913325
FCF margin (%): -23.744789544614033
Revenue growth (%): 25.10218684754801
Rule of 40 score: 1.3573973029339754
Financial ratios for BLZE — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 6.02
Shares outstanding: 60014731
Market cap (USD): 361288680.61999995
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BLZE — quarterly report dated 2025-03-31
Total revenue: 34613000
Gross profit: 19256000
Operating income: -8771000
Net income: -9324000
Capital expenditures: 489000
Operating cash flow: 4943000
Depreciation & amortization: 7764000
Net tangible assets: 35615000
Owner earnings: -2049000
Return on net tangible assets (%): -5.753193878983574
Buffett classification: The Gruesome
Stock price: 4.83
Shares outstanding: 60014731
Book value: 77768000
P/B ratio: 3.7273833804392553
Market cap (USD): 289871150.73
Debt to equity: 0.6151759078284127
Current ratio: 1.0931651954602775
Quick ratio: 1.0931651954602775
Interest coverage ratio: -10.28253223915592
COGS to revenue (%): 44.367723109814236
R&D to revenue (%): 34.25013723167596
SG&A to revenue (%): 46.72232976049461
Free cash flow (dilution-adjusted): -5042000
Buyback yield (%): 0
Retained earnings: -205309000
Receivables turnover: 19.555367231638417
Capitalized R&D asset: 11855000
ROCI (R&D-adjusted, %): -0.7080450015232622
FCF margin (%): -14.566781267153958
Rule of 40 score: -14.566781267153958
Financial ratios for BLZE — quarterly report dated 2025-06-30
Total revenue: 36298000
Gross profit: 23041000
Operating income: -6717000
Net income: -7097000
Capital expenditures: 768000
Operating cash flow: 3545000
Depreciation & amortization: 5474000
Net tangible assets: 37459000
Owner earnings: -2391000
Return on net tangible assets (%): -6.382978723404255
Buffett classification: The Gruesome
Stock price: 5.5
Shares outstanding: 60014731
Book value: 79642000
P/B ratio: 4.144559660731774
Market cap (USD): 330081020.5
Debt to equity: 0.7734235704778886
Current ratio: 1.0757585873084754
Quick ratio: 1.0757585873084754
Interest coverage ratio: -7.632954545454545
COGS to revenue (%): 36.522673425533085
R&D to revenue (%): 32.72356603669624
SG&A to revenue (%): 49.25891233676787
Free cash flow (dilution-adjusted): -6604000
Buyback yield (%): 0
Retained earnings: -212406000
Receivables turnover: 11.203086419753086
Capitalized R&D asset: 19820850
ROCI (R&D-adjusted, %): -1.8841830370769537
Rosenberg metric: 0.31927456769295653
FCF margin (%): -18.193839880985177
Revenue growth (%): 4.86811313668275
Rule of 40 score: -13.325726744302427
Financial ratios for BLZE — quarterly report dated 2025-09-30
Total revenue: 37162000
Gross profit: 23071000
Operating income: -3321000
Net income: -3778000
Capital expenditures: 3018000
Operating cash flow: 5743000
Depreciation & amortization: 6044000
Net tangible assets: 41369000
Owner earnings: -752000
Return on net tangible assets (%): -1.817786265077715
Buffett classification: The Gruesome
Stock price: 9.28
Shares outstanding: 60014731
Book value: 82829000
P/B ratio: 6.723933690857067
Market cap (USD): 556936703.68
Debt to equity: 0.7743061005203492
Current ratio: 1.0963040434540579
Quick ratio: 1.0963040434540579
Interest coverage ratio: -3.5556745182012848
COGS to revenue (%): 37.91776545934019
R&D to revenue (%): 30.232495559980627
SG&A to revenue (%): 40.78628706743447
Free cash flow (dilution-adjusted): -4550000
Buyback yield (%): 0
Retained earnings: -216184000
Receivables turnover: 11.053539559785841
Capitalized R&D asset: 23105410
ROCI (R&D-adjusted, %): -2.4086860488865427
Rosenberg metric: 0.0025256777235224785
FCF margin (%): -12.243689790646359
Revenue growth (%): 2.380296435065293
Rule of 40 score: -9.863393355581065
Financial ratios for BLZE — quarterly report dated 2025-12-31
Total revenue: 37762000
Gross profit: 23425000
Operating income: -4665000
Net income: -5413000
Capital expenditures: 252000
Operating cash flow: 9313000
Depreciation & amortization: 6309000
Net tangible assets: 42396000
Owner earnings: 644000
Buffett classification: The Gruesome
Stock price: 4.66
Shares outstanding: 60014731
Book value: 83221000
P/B ratio: 3.36055378402086
Market cap (USD): 279668646.46000004
Debt to equity: 0.740005527451004
Current ratio: 1.0660521276250445
Quick ratio: 1.0660521276250445
Interest coverage ratio: -3.8907422852376983
COGS to revenue (%): 37.96673904983846
R&D to revenue (%): 29.503204279434353
SG&A to revenue (%): 44.883745564323924
Free cash flow (dilution-adjusted): 1046000
Buyback yield (%): 0.28533767016823425
Retained earnings: -221597000
Receivables turnover: 4.814739257937014
Capitalized R&D asset: 22588190
ROCI (R&D-adjusted, %): -3.2343738413896315
Rosenberg metric: 0.0315086782376502
FCF margin (%): 2.769980403580319
Revenue growth (%): 1.614552499865454
Rule of 40 score: 4.3845329034457725
Financial ratios for BLZE — annual report dated 2025-12-31
Total revenue: 145835000
Gross profit: 88793000
Operating income: -23623000
Net income: -25612000
Capital expenditures: 4527000
Operating cash flow: 23544000
Depreciation & amortization: 25591000
Net tangible assets: 42396000
Owner earnings: -4548000
Return on net tangible assets (%): -10.727427115765638
Buffett classification: The Gruesome
Stock price: 4.66
Shares outstanding: 60014731
Book value: 83221000
P/B ratio: 3.36055378402086
Market cap (USD): 279668646.46000004
Debt to equity: 0.740005527451004
Current ratio: 1.0660521276250445
Quick ratio: 1.0660521276250445
Interest coverage ratio: -6.1104500775995865
COGS to revenue (%): 39.11406726780265
R&D to revenue (%): 31.617238660129598
SG&A to revenue (%): 45.467137518428366
Free cash flow (dilution-adjusted): -15150000
Buyback yield (%): 0.7090533833879806
Retained earnings: -221597000
Receivables turnover: 18.59428790003825
Capitalized R&D asset: 87358570
ROCI (R&D-adjusted, %): -9.234874640897267
Rosenberg metric: 0.46201719796664925
FCF margin (%): -10.388452703397675
Revenue growth (%): 14.26567837778544
Rule of 40 score: 3.8772256743877644
Financial ratios for BMV.L — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.0004054054054054054
Shares outstanding: 2857000804
Market cap (USD): 1158243.5691891892
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BMV.L — annual report dated 2022-12-31
Total revenue: 0
Operating income: -1094240.9638554216
Net income: -1790127.7108433736
Capital expenditures: 0
Net tangible assets: 22012575.903614458
Owner earnings: -1790127.7108433736
Return on net tangible assets (%): -8.132295460021265
Buffett classification: The Gruesome
Stock price: 0.00024096385542168676
Shares outstanding: 2857000804
Book value: 22012575.903614458
P/B ratio: 0.031274573756797736
Market cap (USD): 688433.9286746988
Debt to equity: 0.05481302637626969
Current ratio: 0.14602754878165347
Quick ratio: 0.14602754878165347
Interest coverage ratio: -3.6235168325048073
Free cash flow (dilution-adjusted): -674695.1807228916
Buyback yield (%): 0
Retained earnings: -4443372.289156627
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -4.970980991260308
Rule of 40 score: 0
Financial ratios for BMV.L — annual report dated 2023-12-31
Total revenue: 0
Operating income: -1008682.2784810126
Net income: -320916.4556962025
Capital expenditures: 0
Net tangible assets: 24489743.03797468
Owner earnings: -320916.4556962025
Return on net tangible assets (%): -1.310411690308787
Buffett classification: The Gruesome
Stock price: 0
Shares outstanding: 2857000804
Book value: 24489743.03797468
P/B ratio: 0
Market cap (USD): 0
Debt to equity: 0.018261326351197302
Current ratio: 0.4096763600540008
Quick ratio: 0.4096763600540008
Interest coverage ratio: -30.766756756756756
Free cash flow (dilution-adjusted): -779753.164556962
Retained earnings: -4989269.620253164
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -4.118794864106631
Rule of 40 score: 0
Financial ratios for BMV.L — annual report dated 2024-12-31
Total revenue: 0
Operating income: -810226.25
Net income: -1121947.5
Capital expenditures: 85711.25
Operating cash flow: -559928.75
Depreciation & amortization: 17147.5
Net tangible assets: 23613161.25
Owner earnings: -1190511.25
Return on net tangible assets (%): -5.041727523882471
Buffett classification: The Gruesome
Stock price: 0.000125
Shares outstanding: 2857000804
Book value: 23613161.25
P/B ratio: 0.015123985167382024
Market cap (USD): 357125.1005
Debt to equity: 0.03617564124329181
Current ratio: 0.07675661830553675
Quick ratio: 0.07675661830553675
Interest coverage ratio: -9.413573254327872
Free cash flow (dilution-adjusted): -645640
Buyback yield (%): 0
Retained earnings: -6048851.25
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -3.4312485372961237
Rule of 40 score: 0
Financial ratios for BMV.L — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 23613161.25
Buffett classification: The Gruesome
Stock price: 0.000125
Shares outstanding: 2857000804
Book value: 23613161.25
P/B ratio: 0.015123985167382024
Market cap (USD): 357125.1005
Debt to equity: 0.03617564124329181
Current ratio: 0.07675661830553675
Quick ratio: 0.07675661830553675
Buyback yield (%): 0
Retained earnings: -6048851.25
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BMV.L — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 21300280.82191781
Buffett classification: The Gruesome
Stock price: 0.00013698630136986303
Shares outstanding: 2857000804
Book value: 21300280.821917806
P/B ratio: 0.01837393489892249
Market cap (USD): 391369.97315068496
Debt to equity: 0
Current ratio: 0.06845971244612832
Quick ratio: 0.06845971244612832
Buyback yield (%): 0
Retained earnings: -10221019.178082192
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CAA.AX — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 5.2898550724637685
Shares outstanding: 15842564
Market cap (USD): 83804867.53623189
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CAA.AX — annual report dated 2022-12-31
Total revenue: 434651351.3513514
Gross profit: 117941891.8918919
Operating income: -9433108.108108109
Net income: 27535810.81081081
Capital expenditures: 6614864.864864865
Depreciation & amortization: 14404054.054054054
Net tangible assets: 125680405.4054054
Owner earnings: 35325000
Return on net tangible assets (%): 28.10700672555334
Buffett classification: The Gruesome
Stock price: 4.168918918918919
P/E ratio: 2.3985625568669793
Shares outstanding: 15842564
Book value: 128193243.24324325
P/B ratio: 0.5152094066179649
Market cap (USD): 66046364.78378379
Debt to equity: 0.622555685567608
Current ratio: 1.7226431123369295
Quick ratio: 0.8214514308324314
Effective tax rate (%): -25.827466963072744
Interest coverage ratio: -7.09040121889284
COGS to revenue (%): 72.86517308063002
SG&A to revenue (%): 19.460611487305762
Free cash flow (dilution-adjusted): -1958108.1081081082
Buyback yield (%): 0
Retained earnings: -226341891.8918919
Inventory turnover: 3.0264661634716585
Receivables turnover: 7.043821036725577
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -5.078463183779183
FCF margin (%): -0.45050086742403045
Rule of 40 score: -0.45050086742403045
Financial ratios for CAA.AX — annual report dated 2023-12-31
Total revenue: 421126027.3972603
Gross profit: 131252054.79452056
Operating income: -5360958.904109589
Net income: 21807534.246575344
Capital expenditures: 5947945.205479452
Depreciation & amortization: 15759589.04109589
Net tangible assets: 137741095.89041096
Owner earnings: 31619178.082191788
Return on net tangible assets (%): 22.95551511173435
Buffett classification: The Gruesome
Stock price: 5.938356164383562
P/E ratio: 4.314049746537265
Shares outstanding: 15842564
Book value: 140227397.260274
P/B ratio: 0.6709016171385029
Market cap (USD): 94078787.5890411
Debt to equity: 0.43380126213781917
Current ratio: 1.9884264730106211
Quick ratio: 1.0849608605662149
Effective tax rate (%): 0
Interest coverage ratio: -3.475577264653641
COGS to revenue (%): 68.83306985186486
SG&A to revenue (%): 23.357632179870013
Free cash flow (dilution-adjusted): 45391095.89041096
Buyback yield (%): 2.2896868085192255
Retained earnings: -229442465.75342467
Inventory turnover: 3.3548632580261595
Receivables turnover: 6.8841490040643585
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -2.7408245234985347
FCF margin (%): 10.778506417888115
Revenue growth (%): -3.111763925739609
Rule of 40 score: 7.666742492148506
Financial ratios for CAA.AX — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 135932298.13664594
Buffett classification: The Gruesome
Stock price: 5.807453416149068
Shares outstanding: 15842564
Book value: 139831677.01863357
P/B ratio: 0.65796931270516
Market cap (USD): 92004952.42236024
Debt to equity: 0.36835769714252703
Current ratio: 1.8506086655512606
Quick ratio: 0.9540702705821267
Buyback yield (%): 0
Retained earnings: -205823602.48447204
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CAA.AX — annual report dated 2024-12-31
Total revenue: 375402484.47204965
Gross profit: 120497515.5279503
Operating income: -10101242.236024844
Net income: 20178260.869565215
Capital expenditures: 6020496.894409938
Depreciation & amortization: 14801863.354037266
Net tangible assets: 135932298.13664594
Owner earnings: 28959627.32919254
Return on net tangible assets (%): 21.30444914576584
Buffett classification: The Gruesome
Stock price: 5.807453416149068
P/E ratio: 4.559607639979069
Shares outstanding: 15842564
Book value: 139831677.01863357
P/B ratio: 0.65796931270516
Market cap (USD): 92004952.42236024
Debt to equity: 0.36835769714252703
Current ratio: 1.8506086655512606
Quick ratio: 0.9540702705821267
Effective tax rate (%): -12.501298611351597
Interest coverage ratio: -20.077777777777776
COGS to revenue (%): 67.90177995294492
SG&A to revenue (%): 24.452264898295496
Free cash flow (dilution-adjusted): 26714906.832298134
Buyback yield (%): 4.1983967357782
Retained earnings: -205823602.48447204
Inventory turnover: 2.6409583196586808
Receivables turnover: 6.581920350223791
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -5.437566452458489
FCF margin (%): 7.116337247972362
Revenue growth (%): -10.85744882780145
Rule of 40 score: -3.741111579829088
Financial ratios for CAE — annual report dated 2022-03-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 26.08
Shares outstanding: 321579686
Market cap (USD): 8386798210.879999
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CAE — annual report dated 2023-03-31
Total revenue: 2970814814.8148146
Gross profit: 802592592.5925926
Operating income: 333111111.1111111
Net income: 171777777.77777776
Capital expenditures: 217185185.18518516
Operating cash flow: 302518518.5185185
Depreciation & amortization: 253481481.48148146
Net tangible assets: 338444444.4444444
Owner earnings: 208074074.07407406
Return on net tangible assets (%): 61.479536003501856
Capex to operating income (%): 65.19902156993551
Buffett classification: The Good
Stock price: 22.63
P/E ratio: 42.364899513337654
Shares outstanding: 321579686
Book value: 3399185185.1851845
P/B ratio: 2.1409096291361767
Market cap (USD): 7277348294.179999
Debt to equity: 0.7082525223909871
Current ratio: 0.9947923621311257
Quick ratio: 0.7351226242934081
Effective tax rate (%): 21.409028727770178
Interest coverage ratio: 2.972240581625909
COGS to revenue (%): 72.98409215578717
R&D to revenue (%): 3.216476337705082
SG&A to revenue (%): 12.58664538971725
Free cash flow (dilution-adjusted): -17037037.037037037
Buyback yield (%): 0
Retained earnings: 1522074074.074074
Inventory turnover: 5.017312307164895
Receivables turnover: 2.9537487111503906
Capitalized R&D asset: 95555555.55555555
ROCI (R&D-adjusted, %): 6.43963071596865
FCF margin (%): -0.5734802772652471
Rule of 40 score: -0.5734802772652471
Financial ratios for CAE — annual report dated 2024-03-31
Total revenue: 3172444444.444444
Gross profit: 855185185.1851851
Operating income: 347925925.9259259
Net income: -219481481.48148146
Capital expenditures: 2962962.9629629627
Operating cash flow: 419925925.9259259
Depreciation & amortization: 277629629.6296296
Net tangible assets: 705925925.9259259
Owner earnings: 55185185.18518519
Capex to operating income (%): 0.8516074089844582
Buffett classification: The Great
Stock price: 20.64
Shares outstanding: 321579686
Book value: 3187111111.111111
P/B ratio: 2.082577132595175
Market cap (USD): 6637404719.04
Debt to equity: 0.7145214521452145
Current ratio: 0.8507886702849389
Quick ratio: 0.6075729308005428
Interest coverage ratio: 2.606548279689234
COGS to revenue (%): 73.04333613523863
R&D to revenue (%): 3.497711777341926
SG&A to revenue (%): 12.491827776221164
Free cash flow (dilution-adjusted): 55111111.111111104
Buyback yield (%): 0
Retained earnings: 1305629629.6296296
Inventory turnover: 5.453800557880056
Receivables turnover: 3.5761523046092183
Capitalized R&D asset: 174985185.1851852
ROCI (R&D-adjusted, %): 6.827949250922487
Rosenberg metric: 0.5503875968992237
FCF margin (%): 1.7371812832726252
Revenue growth (%): 6.787014411808707
Rule of 40 score: 8.524195695081332
Financial ratios for CAE — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 18.75
Shares outstanding: 321579686
Market cap (USD): 6029619112.5
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CAE — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 25.38
Shares outstanding: 321579686
Market cap (USD): 8161692430.679999
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CAE — quarterly report dated 2025-03-31
Total revenue: 891888111.888112
Gross profit: 273216783.2167832
Operating income: 143496503.4965035
Net income: 96643356.64335665
Capital expenditures: 11258741.25874126
Operating cash flow: 225664335.66433567
Depreciation & amortization: 77272727.27272728
Net tangible assets: 713636363.6363636
Owner earnings: 162657342.65734267
Return on net tangible assets (%): 22.792748652621267
Capex to operating income (%): 7.8460038986354785
Buffett classification: The Great
Stock price: 24.59
P/E ratio: 20.455737345510492
Shares outstanding: 321579686
Book value: 3479720279.7202797
P/B ratio: 2.272494293528577
Market cap (USD): 7907644478.74
Debt to equity: 0.697427652733119
Current ratio: 0.7979155034431417
Quick ratio: 0.5764377442769403
Effective tax rate (%): 24.645583424209377
Interest coverage ratio: 3.976744186046512
COGS to revenue (%): 69.36647326328995
R&D to revenue (%): 1.6779049709894935
SG&A to revenue (%): 12.866551670064293
Free cash flow (dilution-adjusted): 135874125.87412587
Buyback yield (%): 0
Retained earnings: 1477482517.4825175
Inventory turnover: 1.4868907563025209
Receivables turnover: 1.10596600763094
Capitalized R&D asset: 14965034.965034965
ROCI (R&D-adjusted, %): 2.567251940840907
FCF margin (%): 15.234436255292454
Rule of 40 score: 15.234436255292454
Financial ratios for CAE — annual report dated 2025-03-31
Total revenue: 3292237762.2377625
Gross profit: 909160839.1608392
Operating income: 427622377.62237763
Net income: 290209790.2097902
Capital expenditures: 13566433.566433568
Operating cash flow: 626923076.923077
Depreciation & amortization: 290000000
Net tangible assets: 713636363.6363636
Owner earnings: 566643356.6433567
Return on net tangible assets (%): 79.40225379715827
Capex to operating income (%): 3.172526573998365
Buffett classification: The Great
Stock price: 24.59
P/E ratio: 27.248027962887228
Shares outstanding: 321579686
Book value: 3479720279.7202797
P/B ratio: 2.272494293528577
Market cap (USD): 7907644478.74
Debt to equity: 0.697427652733119
Current ratio: 0.7979155034431417
Quick ratio: 0.5764377442769403
Effective tax rate (%): 19.213548763869962
Interest coverage ratio: 3.1536874677668902
COGS to revenue (%): 72.38471505342085
R&D to revenue (%): 2.6168780135516894
SG&A to revenue (%): 12.009600883621149
Free cash flow (dilution-adjusted): 298741258.74125874
Buyback yield (%): 0.1883633607346783
Retained earnings: 1477482517.4825175
Inventory turnover: 5.7273949579831935
Receivables turnover: 4.0824661810613945
Capitalized R&D asset: 192032364.67236468
ROCI (R&D-adjusted, %): 6.762090170835059
Rosenberg metric: 0.4864294583920766
FCF margin (%): 9.074109475562352
Revenue growth (%): 3.776057229405522
Rule of 40 score: 12.850166704967874
Financial ratios for CAE — quarterly report dated 2025-06-30
Total revenue: 801897810.218978
Gross profit: 225036496.35036495
Operating income: 81897810.21897809
Net income: 43941605.83941606
Capital expenditures: 3722627.737226277
Operating cash flow: -11167883.21167883
Depreciation & amortization: 82992700.729927
Net tangible assets: 859708029.1970803
Owner earnings: 123211678.83211678
Return on net tangible assets (%): 14.331805060281882
Capex to operating income (%): 4.545454545454546
Buffett classification: The Great
Stock price: 29.27
P/E ratio: 66.95337284294133
Shares outstanding: 321579686
Book value: 3643138686.1313868
P/B ratio: 2.583661567716816
Market cap (USD): 9412637409.22
Debt to equity: 0.6826751617879826
Current ratio: 0.8655538694992413
Quick ratio: 0.5983091263819641
Effective tax rate (%): 23.98989898989899
Interest coverage ratio: 2.3229813664596275
COGS to revenue (%): 71.93701074094302
R&D to revenue (%): 3.340615328600036
SG&A to revenue (%): 14.509375568905881
Free cash flow (dilution-adjusted): -119781021.89781022
Buyback yield (%): 0
Retained earnings: 1598248175.1824815
Inventory turnover: 1.2821219987021415
Receivables turnover: 1.006043956043956
Capitalized R&D asset: 36814894.594456635
ROCI (R&D-adjusted, %): 1.505718528829512
Rosenberg metric: -3.2195238420083236
FCF margin (%): -14.937192790824689
Revenue growth (%): -10.089864465019717
Rule of 40 score: -25.027057255844404
Financial ratios for CAE — quarterly report dated 2025-09-30
Total revenue: 889640287.7697842
Gross profit: 229712230.21582735
Operating income: 96402877.69784173
Net income: 54748201.43884893
Capital expenditures: 0
Operating cash flow: 153956834.5323741
Depreciation & amortization: 82014388.48920864
Net tangible assets: 940287769.7841728
Owner earnings: 136762589.92805755
Return on net tangible assets (%): 14.544758990053555
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 29.64
P/E ratio: 48.79674143231822
Shares outstanding: 321579686
Book value: 3712230215.8273387
P/B ratio: 2.567626827776279
Market cap (USD): 9531621893.04
Debt to equity: 0.6521705426356589
Current ratio: 0.8345738589890398
Quick ratio: 0.5945525928349419
Effective tax rate (%): 22.66260162601626
Interest coverage ratio: 2.3550087873462213
COGS to revenue (%): 74.17920103509623
R&D to revenue (%): 2.9920750444767914
SG&A to revenue (%): 11.992560245835355
Free cash flow (dilution-adjusted): 71870503.59712231
Buyback yield (%): 0.017359860447266083
Retained earnings: 1641582733.8129497
Inventory turnover: 1.5629579144658374
Receivables turnover: 1.0468128333192246
Capitalized R&D asset: 49505341.75691451
ROCI (R&D-adjusted, %): 1.599145408705694
Rosenberg metric: 0.1745437437515934
FCF margin (%): 8.078602620087336
Revenue growth (%): 10.941852743910836
Rule of 40 score: 19.020455363998174
Financial ratios for CAE — quarterly report dated 2025-12-31
Total revenue: 913941605.839416
Gross profit: 264379562.0437956
Operating income: 127372262.77372262
Net income: 81824817.51824817
Capital expenditures: 0
Operating cash flow: 297518248.17518246
Depreciation & amortization: 84306569.3430657
Net tangible assets: 1065766423.3576641
Owner earnings: 166131386.86131388
Return on net tangible assets (%): 15.587973426477642
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 30.42
P/E ratio: 35.295588448504894
Shares outstanding: 321579686
Book value: 3832116788.321167
P/B ratio: 2.5527546754141723
Market cap (USD): 9782454048.12
Debt to equity: 0.6182857142857143
Current ratio: 0.9144416705454238
Quick ratio: 0.6910675750010579
Effective tax rate (%): 20.889202540578687
Interest coverage ratio: 3.22550831792976
COGS to revenue (%): 71.0725980353007
R&D to revenue (%): 2.0765114607459467
SG&A to revenue (%): 12.914303969331522
Free cash flow (dilution-adjusted): 247372262.77372262
Buyback yield (%): 0.011938550448936448
Retained earnings: 1748467153.2846713
Inventory turnover: 1.6857359348361431
Receivables turnover: 1.1775604250916958
Capitalized R&D asset: 45652780.5492832
ROCI (R&D-adjusted, %): 1.919164615014959
Rosenberg metric: 1.3023673308344825
FCF margin (%): 27.066528232569283
Revenue growth (%): 2.7315892056273836
Rule of 40 score: 29.798117438196666
Financial ratios for CARYSIL.NS — annual report dated 2022-03-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 10.835025715416062
Shares outstanding: 28442606
Market cap (USD): 308176367.4234472
Buyback yield (%): 0
Retained earnings: 19391164.44678887
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CARYSIL.NS — annual report dated 2023-03-31
Total revenue: 71573800.24360536
Gross profit: 28120925.70036541
Operating income: 10711400.73081608
Net income: 6434896.46772229
Capital expenditures: 7030097.442143728
Operating cash flow: 8667697.929354446
Depreciation & amortization: 3210280.146163216
Net tangible assets: 24144177.831912305
Owner earnings: 2615079.171741779
Return on net tangible assets (%): 10.831096382521364
Capex to operating income (%): 65.63191517910954
Buffett classification: The Good
Stock price: 6.591230207064556
P/E ratio: 29.133609961745584
Shares outstanding: 28442606
Book value: 37397649.208282575
P/B ratio: 5.012929095910008
Market cap (USD): 187471763.8348356
Debt to equity: 0.7654457297497647
Current ratio: 1.1374269137748483
Quick ratio: 0.7167093170799922
Effective tax rate (%): 22.418527742860164
Interest coverage ratio: 6.3472103933597985
COGS to revenue (%): 60.710587387208314
SG&A to revenue (%): 12.352896229524852
Free cash flow (dilution-adjusted): 1434774.6650426309
Buyback yield (%): 0
Retained earnings: 22685676.00487211
Inventory turnover: 2.732219608059382
Receivables turnover: 5.702056781771145
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 21.87795894017263
FCF margin (%): 2.004608753704982
Rule of 40 score: 2.004608753704982
Financial ratios for CARYSIL.NS — annual report dated 2024-03-31
Total revenue: 81429427.98896751
Gross profit: 35227245.4730783
Operating income: 12405564.216332894
Net income: 6998441.060079146
Capital expenditures: 11016908.50221849
Operating cash flow: 6403645.521045689
Depreciation & amortization: 3890154.694807531
Net tangible assets: 24170763.880561218
Owner earnings: -128312.74733181298
Return on net tangible assets (%): -0.5308592974796529
Capex to operating income (%): 88.80618656355726
Buffett classification: The Gruesome
Stock price: 11.722648752399232
P/E ratio: 47.64242163055556
Shares outstanding: 28442606
Book value: 42945197.26585922
P/B ratio: 7.763910773928355
Market cap (USD): 333422679.74088293
Debt to equity: 0.8718585948843963
Current ratio: 1.1662721226468267
Quick ratio: 0.678221170104836
Effective tax rate (%): 27.754394652141617
Interest coverage ratio: 5.081041257367388
COGS to revenue (%): 56.73892554194156
SG&A to revenue (%): 13.580937794533456
Free cash flow (dilution-adjusted): -4818323.539992805
Buyback yield (%): 0
Retained earnings: 27195107.327017628
Inventory turnover: 2.224737267582862
Receivables turnover: 4.928078960737354
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 21.119572096441626
FCF margin (%): -5.917177191328935
Revenue growth (%): 13.769881872721552
Rule of 40 score: 7.852704681392617
Financial ratios for CARYSIL.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 41064261.825131394
Buffett classification: The Gruesome
Stock price: 9.52269469660774
Shares outstanding: 28442606
Book value: 59604634.495938845
P/B ratio: 4.544113987182621
Market cap (USD): 270850253.3139035
Debt to equity: 0.5372838219674957
Current ratio: 1.504858681770226
Quick ratio: 0.9357265811538675
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CARYSIL.NS — annual report dated 2025-03-31
Total revenue: 95343698.85433714
Gross profit: 51266074.35118073
Operating income: 11856441.430909514
Net income: 7519289.22141688
Capital expenditures: 5494505.494505494
Operating cash flow: -804302.0808978255
Depreciation & amortization: 4196866.962824409
Net tangible assets: 43843815.75870937
Owner earnings: 6221650.689735795
Return on net tangible assets (%): 14.190486348122866
Capex to operating income (%): 46.341944389666736
Buffett classification: The Good
Stock price: 7.260357101178667
P/E ratio: 27.46316445176117
Shares outstanding: 28442606
Book value: 62115969.13724572
P/B ratio: 3.324482887675083
Market cap (USD): 206503476.44812697
Debt to equity: 0.520269507283472
Current ratio: 1.505318844724049
Quick ratio: 0.8729482413497284
Effective tax rate (%): 26.784291405805355
Interest coverage ratio: 4.334188034188034
COGS to revenue (%): 46.230243878514415
SG&A to revenue (%): 14.268548377208578
Free cash flow (dilution-adjusted): -6339724.105681553
Buyback yield (%): 0
Retained earnings: 31427402.38484919
Inventory turnover: 1.7049832685176811
Receivables turnover: 5.585713307307718
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 15.956827514592739
FCF margin (%): -6.649337273318048
Revenue growth (%): 17.087521316316764
Rule of 40 score: 10.438184042998715
Financial ratios for CARYSIL.NS — quarterly report dated 2025-03-31
Total revenue: 23869534.72059855
Gross profit: 12923778.349310264
Operating income: 3122515.78209025
Net income: 2197802.1978021977
Capital expenditures: 0
Depreciation & amortization: 960953.9396773438
Net tangible assets: 43843815.75870937
Owner earnings: 3158756.1374795414
Return on net tangible assets (%): 7.204564846416382
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 7.260357101178667
P/E ratio: 23.489770445974443
Shares outstanding: 28442606
Book value: 62115969.13724572
P/B ratio: 3.324482887675083
Market cap (USD): 206503476.44812697
Debt to equity: 0.520269507283472
Current ratio: 1.505318844724049
Quick ratio: 0.8729482413497284
Effective tax rate (%): 20.186598812553008
Interest coverage ratio: 4.928044280442805
COGS to revenue (%): 45.85659712018806
Buyback yield (%): 0
Retained earnings: 31427402.38484919
Inventory turnover: 0.4233969431129601
Receivables turnover: 1.3983973700431476
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.202394625466102
Rule of 40 score: 0
Financial ratios for CARYSIL.NS — quarterly report dated 2025-06-30
Total revenue: 26560964.193774868
Gross profit: 13969108.354785865
Operating income: 4026445.120524222
Net income: 2680786.3327872693
Capital expenditures: 0
Depreciation & amortization: 1104610.3440205946
Owner earnings: 3785396.6768078636
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 10.15223496372572
P/E ratio: 26.928294840309906
Shares outstanding: 28442606
Market cap (USD): 288756019.0926749
Effective tax rate (%): 24.46422683811408
Interest coverage ratio: 6.443820224719101
COGS to revenue (%): 47.40737477421912
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 11.27558414808024
Rule of 40 score: 11.27558414808024
Financial ratios for CARYSIL.NS — quarterly report dated 2025-09-30
Total revenue: 27133032.69447576
Gross profit: 14074408.117249154
Operating income: 4122886.1330326945
Net income: 3091319.0529875983
Capital expenditures: 0
Depreciation & amortization: 1075535.5129650508
Net tangible assets: 46655016.91093574
Owner earnings: 4166854.5659526493
Return on net tangible assets (%): 8.931203634342605
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 9.497745208568208
P/E ratio: 33.895076200425464
Shares outstanding: 28442606
Book value: 64414881.623449825
P/B ratio: 4.193761100654579
Market cap (USD): 270140624.85569334
Debt to equity: 0.42099551946233554
Current ratio: 1.4451507446422085
Quick ratio: 0.8626433501115666
Effective tax rate (%): 24.54595487066593
Interest coverage ratio: 7.524691358024692
COGS to revenue (%): 48.12814226949765
Buyback yield (%): 0
Inventory turnover: 0.5159235668789808
Receivables turnover: 1.3099825821902895
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.539733995819069
Revenue growth (%): 2.1537941790342368
Rule of 40 score: 2.1537941790342368
Financial ratios for CARYSIL.NS — quarterly report dated 2025-12-31
Total revenue: 24793360.810961347
Gross profit: 13596970.034532696
Operating income: 3638186.4765511868
Net income: 2368274.4792246856
Capital expenditures: 0
Depreciation & amortization: 1060487.9135568675
Owner earnings: 3428762.392781553
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 10.011139578923917
P/E ratio: 27.54284040700776
Shares outstanding: 28442606
Market cap (USD): 284742898.6543389
Effective tax rate (%): 27.687074829931973
Interest coverage ratio: 6.89029535864979
COGS to revenue (%): 45.158826436626676
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -8.622964892497126
Rule of 40 score: -8.622964892497126
Financial ratios for CON.DE — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 64.875
Shares outstanding: 200005983
Market cap (USD): 12975388147.125
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CON.DE — annual report dated 2022-12-31
Total revenue: 41924361702.12766
Gross profit: 8065212765.957447
Operating income: 15425531.914893618
Net income: 119361702.12765957
Capital expenditures: 2307553191.489362
Operating cash flow: 2442021276.5957446
Depreciation & amortization: 3416170212.765958
Net tangible assets: 9646063829.787235
Owner earnings: 1227978723.4042559
Return on net tangible assets (%): 12.730360746859597
Capex to operating income (%): 14959.310344827585
Buffett classification: The Gruesome
Stock price: 38.191489361702125
P/E ratio: 63.99478422192512
Shares outstanding: 200005983
Book value: 14611702127.659576
P/B ratio: 0.5227677313214415
Market cap (USD): 7638526372.021276
Debt to equity: 0.5587258827812158
Current ratio: 1.137014460723155
Quick ratio: 0.7372057652776292
Effective tax rate (%): 79.84913793103448
Interest coverage ratio: 0.06079664570230608
COGS to revenue (%): 80.7624673614336
R&D to revenue (%): 10.294121378673344
SG&A to revenue (%): 8.89164630324622
Free cash flow (dilution-adjusted): 134468085.106383
Buyback yield (%): 0
Retained earnings: 10543085106.382978
Inventory turnover: 4.729563860613716
Receivables turnover: 4.990932232367878
Capitalized R&D asset: 4315744680.851064
ROCI (R&D-adjusted, %): 10.810535006911392
FCF margin (%): 0.32073973138047496
Rule of 40 score: 0.32073973138047496
Financial ratios for CON.DE — annual report dated 2023-12-31
Total revenue: 46023333333.333336
Gross profit: 9786666666.666666
Operating income: 862222222.2222222
Net income: 1326666666.6666667
Capital expenditures: 118888888.88888888
Operating cash flow: 3697777777.7777777
Depreciation & amortization: 2408888888.888889
Net tangible assets: 10741111111.11111
Owner earnings: 3616666666.6666665
Return on net tangible assets (%): 33.671252715423606
Capex to operating income (%): 13.788659793814432
Buffett classification: The Great
Stock price: 56.56666666666666
P/E ratio: 8.527893295251255
Shares outstanding: 200005983
Book value: 15694444444.444447
P/B ratio: 0.7208711217366369
Market cap (USD): 11313671771.699999
Debt to equity: 0.5070442477876106
Current ratio: 1.2282278313730672
Quick ratio: 0.8134663671203911
Effective tax rate (%): 26.20519159456119
Interest coverage ratio: 1.843230403800475
COGS to revenue (%): 78.73542406025928
R&D to revenue (%): 9.961130827358103
SG&A to revenue (%): 9.37447188624128
Free cash flow (dilution-adjusted): 1317777777.7777777
Buyback yield (%): 0
Retained earnings: 11963333333.333334
Inventory turnover: 5.195634857415962
Receivables turnover: 5.381447317136547
Capitalized R&D asset: 7475993380.614657
ROCI (R&D-adjusted, %): 7.605251966069185
Rosenberg metric: 0.3988776046802075
FCF margin (%): 2.863281910142198
Revenue growth (%): 9.77706389504232
Rule of 40 score: 12.640345805184516